Search research articles
Contact Us
Filters
Showing results (31-40 of 36) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 36 results.
Critical Care Medicine
|
January 1, 1988
Effect of the calcium entry blocker verapamil on renal ischemia
J L Woolley, G R Barker, W K Jacobsen, et al.
The Journal of Infectious Diseases
|
April 16, 1998
Effects of aerosolized synthetic surfactant, atovaquone, and the combination of these on murine Pneumocystis carinii pneumonia
W T Hughes, E M Sillos, S LaFon, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1989
A phase I clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U)
G R Weiss, G A Sarosy, T D Shenkenberg, et al.
Journal of Clinical Pharmacology
|
April 18, 2001
Metabolic disposition and pharmacokinetics of [14C]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjects
B M Sadler, G E Chittick, R E Polk, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Preclinical biochemical pharmacology and toxicology of piritrexim, a lipophilic inhibitor of dihydrofolate reductase
C W Sigel, A W Macklin, J L Woolley, et al.
Stem Cells (Dayton, Ohio)
|
December 22, 1999
Pharmacokinetics and hematological effects of the PEGylated thrombopoietin peptide mimetic GW395058 in rats and monkeys after intravenous or subcutaneous administration
M de Serres, R L Yeager, J E Dillberger, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 36) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 36 results.
Critical Care Medicine
|
January 1, 1988
Effect of the calcium entry blocker verapamil on renal ischemia
J L Woolley, G R Barker, W K Jacobsen, et al.
The Journal of Infectious Diseases
|
April 16, 1998
Effects of aerosolized synthetic surfactant, atovaquone, and the combination of these on murine Pneumocystis carinii pneumonia
W T Hughes, E M Sillos, S LaFon, et al.
European Journal of Cancer & Clinical Oncology
|
December 1, 1989
A phase I clinical and pharmacological study of weekly intravenous infusions of piritrexim (BW301U)
G R Weiss, G A Sarosy, T D Shenkenberg, et al.
Journal of Clinical Pharmacology
|
April 18, 2001
Metabolic disposition and pharmacokinetics of [14C]-amprenavir, a human immunodeficiency virus type 1 (HIV-1) protease inhibitor, administered as a single oral dose to healthy male subjects
B M Sadler, G E Chittick, R E Polk, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Preclinical biochemical pharmacology and toxicology of piritrexim, a lipophilic inhibitor of dihydrofolate reductase
C W Sigel, A W Macklin, J L Woolley, et al.
Stem Cells (Dayton, Ohio)
|
December 22, 1999
Pharmacokinetics and hematological effects of the PEGylated thrombopoietin peptide mimetic GW395058 in rats and monkeys after intravenous or subcutaneous administration
M de Serres, R L Yeager, J E Dillberger, et al.
Page
of 4